{"listing":{"listing_type":"company","name":"Abalone Bio","slug":"abalone-bio","tagline":"We create activating antibodies to treat diseases others can’t.","description":"Abalone Bio is tackling challenging undrugged targets underlying diseases affecting millions, focusing first cell-specific antibody drugs to treat obesity and metabolic disease without the GI side effects that cause 25% of GLP-1 drug patients to quit after 1 year. \n\n+ High throughput experimental measurement uniquely leverages AI/ML:  We’ve engineered cells to measure antibodies for pharmacological activity, not just structure or binding like others, 100 million at a time, 100X+ the throughput of others. With our large, proprietary activity datasets, we uniquely leverage ML to both unlock the discovery of rare hits and generate optimized hits for challenging targets, starting with G-protein coupled receptors (GPCRs)\n\n+ Proven success: We have developed antibody agonists (activators) for 2 out of the 8 G-protein coupled receptors ever drugged by biotech.\n\n+ Pharma traction: We’ve secured 3 partnerships with $3M in revenue and $125M in downstream value. \n\n+ Externally validated science: We’ve been awarded $7M in non-dilutive grant funding for platform and program development.\n\nAbalone Bio is a Y Combinator company (Winter 2020). YC-listed status: Active.","url":"https://www.abalonebio.com/","is_stealth":false,"normalized_domain":"abalonebio.com","normalized_url_key":"abalonebio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e9f1d41bc9bfabd8ecaa9963112dc25b23472f0a.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/abalone-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.abalonebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.abalonebio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Machine Learning","Synthetic Biology","Therapeutics","Drug discovery"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:27:15.102Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2020","Machine Learning","Synthetic Biology","Therapeutics","Drug discovery"],"one_liner_for_search":"Abalone Bio — We create activating antibodies to treat diseases others can’t. (Y Combinator Winter 2020)","canonical_facts":["Y Combinator batch: Winter 2020","YC company status: Active","Team size (per YC directory): 14","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Abalone Bio, Inc","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:27:15.102Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"machine-learning","name":"Machine Learning","note":null,"profile_url":"/industries/machine-learning"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}]}}